Authorization of genetically modified maize DP915635 in the European Union

The European Parliament has examined the authorization of genetically modified maize DP915635 for marketing. This decision followed a complex safety assessment for human health, animal health and the environment. The adopted text examines multiple aspects of this genetically modified organism.

Context and objectives

The procedure is based on Regulation (EC) No 1829/2003 on genetically modified food and feed. The main objective is to ensure that GMO products have no adverse effects on health or the environment, while respecting the European legal framework and international obligations.

Key measures

• Analysis of EFSA's assessment of 30 November 2023 on the safety of maize DP915635
• Examination of resistance to glufosinate and produced insecticidal toxin IPD079Ea
• Assessment of potential impact on agricultural practices and environment
• Analysis of Member States' and stakeholders' observations
• Consideration of international obligations on biodiversity and sustainable development

Timeline and implementation

The authorization decision was adopted in 2024 following consultations with Member States and EFSA's assessment. The European Commission monitors implementation, and Member States are responsible for application at national level with regular control mechanisms.

Impact for citizens and stakeholders

Farmers may access new maize varieties but must consider environmental implications. Consumers benefit from a rigorous food safety framework. Producers must comply with strict labeling and monitoring requirements.